Properties
What is it?
International Nonproprietary Name - Phospholipids hypothalamus Active substance: 28 mg hypothalamus phospholipids Excipients: Mannitol. Disodium phosphate dodecahydrate, Sodium phosphate monobasic dihydrate, p-hydroxybenzoic acid esters, Water for injections for 2 ml. Pharmaceutical form Solution for injection for intravenous or intramuscular administration. 28mg/2ml solution for injection, 5 ampoules. Pharmacotherapeutic group Other medicinal products for the nervous system. Indication Used as an adjunct in the treatment of metabolic brain disorders caused by neuroendocrine disorders. Contraindications Hypersensitivity to the components of the product; Infection at the injection site or damage to the skin. Precautions The product does not require special precautions during use. Interactions with other agents Clinically significant interactions of the preparation with other drugs have not been established. It is possible to administer the product during treatment with other pharmaceutical products, such as neuroleptics, anti-hyperprolactinemic drugs, tricyclic antidepressants (reduces latency and increases efficacy), and cardiological drugs. Warnings The product can be taken during pregnancy and lactation under the direct supervision of a doctor. The product does not affect the ability to drive or operate machinery. Dosage and administration 1 ampoule per day by intramuscular or intravenous injection. The course of treatment is determined by the doctor's prescription. Side effects No undesirable side effects have been reported. If side effects occur, please inform your doctor or pharmacist. Overdose No symptoms of overdose have been observed during treatment with recommended doses. In case of accidental overdose, treatment is symptomatic. Storage conditions Store the preparation at a temperature not exceeding 25°C. Keep out of reach of children! Warning: Do not use this product after the expiry date indicated on the packaging